Mupirocin resistance in Staphylococcus aureus causing recurrent skin and soft tissue infections in children

Antimicrob Agents Chemother. 2011 May;55(5):2431-3. doi: 10.1128/AAC.01587-10. Epub 2011 Jan 31.

Abstract

Staphylococcus aureus resistance to mupirocin is often caused by acquisition of a novel isoleucyl-tRNA synthetase encoded on the plasmid gene mupA. We tested S. aureus isolates from children at Texas Children's Hospital with recurrent skin and soft tissue infections for mupirocin resistance and mupA. Of 136 isolates, 20 were resistant to mupirocin (14.7%). Fifteen isolates (11%) carried mupA, and the gene was more common in methicillin-susceptible S. aureus (21.4%) than methicillin-resistant S. aureus (8.3%; P=0.03). Seven of 20 mupirocin-resistant isolates displayed clindamycin resistance.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anti-Bacterial Agents / pharmacology*
  • Anti-Bacterial Agents / therapeutic use*
  • Child
  • Clindamycin / pharmacology
  • Clindamycin / therapeutic use
  • Humans
  • Microbial Sensitivity Tests
  • Mupirocin / pharmacology*
  • Mupirocin / therapeutic use*
  • Soft Tissue Infections / drug therapy
  • Soft Tissue Infections / microbiology
  • Staphylococcal Skin Infections / drug therapy
  • Staphylococcal Skin Infections / microbiology
  • Staphylococcus aureus / drug effects*
  • Staphylococcus aureus / genetics

Substances

  • Anti-Bacterial Agents
  • Clindamycin
  • Mupirocin